These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24726271)

  • 21. Itch in liver disease: facts and speculations.
    Ghent CN; Bloomer JR
    Yale J Biol Med; 1979; 52(1):77-82. PubMed ID: 452625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling.
    Cipriani S; Renga B; D'Amore C; Simonetti M; De Tursi AA; Carino A; Monti MC; Sepe V; Zampella A; Fiorucci S
    PLoS One; 2015; 10(7):e0129866. PubMed ID: 26177448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic targets for cholestatic liver injury.
    Woolbright BL; Jaeschke H
    Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholemic tubulonephrosis].
    Emanuelli G; Camussi G; Gatti G; Anfossi G; Robecchi A; Calcamuggi G; Cestonaro G
    Recenti Prog Med; 1978 Jun; 64(6):671-700. PubMed ID: 370932
    [No Abstract]   [Full Text] [Related]  

  • 28. Production and excretion of cholesterol in mammals. VI. Bile acid accumulation in production of hypercholesteremia occurring after biliary obstruction.
    FRIEDMAN M; BYERS S
    Am J Physiol; 1952 Feb; 168(2):292-6. PubMed ID: 14903143
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
    Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
    Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early growth response factor-1 is critical for cholestatic liver injury.
    Kim ND; Moon JO; Slitt AL; Copple BL
    Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
    Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
    Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
    Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
    Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxemia and cholestasis.
    Roughneen PT; Kumar SC; Pellis NR; Rowlands BJ
    Surg Gynecol Obstet; 1988 Sep; 167(3):205-10. PubMed ID: 3413650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of APh, gamma-GT, GlDH and GPT and bile acid concentrations in serum after bile duct obstruction and cycloheximide in the rat.
    Putzki H; Reichert B; Leemhuis B; Muckle L
    Gastroenterol J; 1991; 51(2):78-80. PubMed ID: 1684501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in bile acid metabolism in cholestasis].
    Back P
    Fortschr Med; 1980 Apr; 98(16):602-5. PubMed ID: 7390373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors producing bile infarction and bile duct proliferation in biliary obstruction.
    Shibayama Y
    J Pathol; 1990 Jan; 160(1):57-62. PubMed ID: 2313481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Graft Failure and Bile Cast Nephropathy.
    Mrzljak A; Jurekovic Z; Novak R; Maksimovic B; Mikulic D; Ljubanovic DG
    Korean J Gastroenterol; 2020 Mar; 75(3):167-171. PubMed ID: 32209806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.